The Big Picture: Let’s face it: HIPAA is inevitableBy Kathy Kincade, EditorI have this bad habit. When it comes to certain tasks, such as paying bills or cleaning the bathroom or taking my (almost daily) walk/run, I can find numerous ways
By Kathy Kincade, Editor
I have this bad habit. When it comes to certain tasks, such as paying bills or cleaning the bathroom or taking my (almost daily) walk/run, I can find numerous ways to delay the inevitable. I consider this masterful multitasking; others call it procrastination.
It is one thing to do this in your personal life, quite another to let it creep into your work. Like many jobs, publishing is built on deadlines. Making them is paramount; missing them can be costly.
The problem is, there always seems to be so much timeuntil, of course, the deadline is tomorrow. Then you scratch your head and wonder where the days went.
When it comes to the new HIPAA regulations, timing is everything. Although most of the proposed rules will be finalized by the first of the year, the deadline for complying with them is still at least two years away. For many vendors, this puts HIPAA on the back burner for the time being.
But product cycles can be long, and what is on the drawing board today is likely to become reality about the time HIPAA finally takes effect. Delaying the inevitable will only make things harderand more expensivein the long run. If you are not doing so already, take a serious look at your products data security and transaction options. Consider the standards you already comply with, and others on which you need to get up to speed. Talk to your customers data-security specialists, not just the radiology managers or CIOs.
Trust mecome 2002, youll be glad you did.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.